Mission is to build transformational human medicine companies that benefit patients and the professionals who serve them. Over half of our portfolio companies were created with our initial investment. We believe that breakthrough science and entrepreneurial innovation have the power to create valuable new ways of treating and diagnosing disease, providing value for our investors and transforming human health. Find Hatteras Venture Partners on LinkedIn.

We invite you to read our descriptive information and contact us if you have a new startup idea or wish to learn more about us. Our team has a long history of creating and building exciting new life science companies. If you have a new startup idea and the desire to build a high quality new company we look forward to hearing from you. Biotechnology and Medical Device Startups. LVP is Registered in the US Patent and Trademark Office.

We are a global investment advisor with a focus on oncology. Nextech is run by an experienced team of experts and supported by key opinion leaders in oncology. We deploy our expertise to invest equity in companies developing cancer therapeutics. PhD, Partner, Founder. PhD, Partner at Nextech Invest. Professor, Swiss Federal Institute of Technology Zurich.

A venture capital firm that is focused on the fields of medical technology and biotechnology. The Vertical Group is the successor to the venture capital division of F. , and has been an independent firm since 1988. Website by Custom Computing Labs.

Learn about our website consulting, design and development services. Housing Projects, Happy Investors.

Delayed at least 20 minutes. SHAPE is a histone deacetylase inhibitor, or HDACi. Altered expression of histone deacetylases, or HDACs, has been linked to tumor development and several drugs approved for systemic use in the treatment of cancers take advantage of this mechanism.